Filter
373
Filtered Results: 373
Text search:
T.
Jans
Featured
Recommendations
26
New Publications
72
Language
Document type
No document type
194
Studies & Reports
88
Guidelines
50
Fact sheets
16
Manuals
14
Training Material
6
Strategic & Response Plan
4
Brochures
1
Countries / Regions
Latin America and the Carribbean
13
South Africa
13
Rwanda
10
Global
10
Kenya
9
Uganda
9
Germany
8
Western and Central Europe
8
Ukraine
7
Eastern Europe
7
Brazil
7
Senegal
6
Congo, Democratic Republic of
6
Russia
6
Malawi
4
Zimbabwe
4
Africa
4
Ethiopia
4
India
4
Burkina Faso
3
Philippines
3
Haiti
3
Asia
3
Zambia
3
Somalia
3
Switzerland
2
Colombia
2
Lesotho
2
Chile
2
Guinea
2
Venezuela
2
West and Central Africa
2
Middle East and North Africa
2
South–East Asia Region
2
East and Southern Africa
2
Tajikistan
1
Thailand
1
Cameroon
1
Nigeria
1
Albania
1
Congo-Brazzaville
1
Niger
1
Austria
1
USA
1
Cambodia
1
Tanzania
1
Jordan
1
Eastern Europe and Central Asia
1
Paraguay
1
North America
1
Spain
1
Argentina
1
Egypt
1
Sudan
1
Central African Republic
1
Honduras
1
Angola
1
Chad
1
South Sudan
1
Indonesia
1
Iraq
1
Liberia
1
Madagascar
1
Pakistan
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
96
Public Health
27
Clinical Guidelines
25
Women & Child Health
13
Capacity Building
3
Key Resources
2
Pharmacy & Technologies
1
Toolboxes
Mental Health
64
COVID-19
54
TB
42
HIV
33
Planetary Health
18
NCDs
15
NTDs
13
Ebola
10
Caregiver
10
Refugee
9
Rapid Response
5
Cholera
5
Pharmacy
5
Zika
5
Global Health Education
5
Health Financing Toolbox
4
Natural Hazards
3
AMR
3
Disability
1
Conflict
1
Polio
1
This second edition of the “living paper” contributes to the global knowledge on how countries are responding to the pandemic by documenting real-time actions in a key area of response – that is, social protection measures planned or implemented by governments.
For the purpose of this revie...
Dieser Leitfaden soll ambulant tätige Ärztinnen und Ärzten in der für diese Klärung erforderlichen qualifizierten Gesprächsführung sowie in derkorrespondierenden, krisentauglichen Dokumentation unterstützen. Dazu werden nach einer Vorbemerkung (II.) Hinweise zur Therapiezielklärung (III.), ...
The main objective of this guidance is to provide scientific advice on public health principles and considerations for infection and prevention control of COVID-19 in migrant and refugee reception and detention centres in the European Union and European Economic Area (EU/EEA) and the United Kingdom ...
The WHO Regional Office for Europe has established the Childhood Obesity Surveillance Initiative in more than half the countries in the Region for routine monitoring of the policy response to the emerging obesity epidemic. The aim of the Initiative is to measure trends in overweight and obesity in c...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
orientaciones provisionales, primera publicación: 24 de mayo de 2021, actualización: 21 de octubre de 2021, actualización: 15 de marzo de 2022
Nature Medicine, https://doi.org/10.1038/s41591-021-01283-z
Pan American Journal of Public Health.
Objetivo. Identificar os fatores associados ao êxito do tratamento da tuberculose multirresistente (TBMR) relacionados ao paciente e à equipe de saúde nos seis municípios da Colômbia com o maior número de casos. Métodos. Mediante regresiones logísticas...
The state of the Guinean health workforce is one of the country’s bottlenecks in advancing health outcomes. The impact of the 2014–2015 Ebola virus disease outbreak and resulting international attention has provided a policy window to invest in the workforce and reform the health system. This re...
The Lancet Published Online
October 8, 2021 https://doi.org/10.1016/ S0140-6736(21)02143-7
The coronavirus disease 2019 (COVID-19) pandemic has created a global and gendered crisis that is compounding existing inequalities and disproportionately affecting girls and women. Emerging evidence from the COVID-19 crisis in 2020 shows school closures, disruptions in essential services and rising...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
A toolkit for pharmacists.
Emerging data show that medication errors and adverse events cause significant harm to patients’ health and
well-being. It is estimated that the burden of adverse events due to medicines is now comparable to that of
widespread diseases, such as malaria or tuberculosis...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
